Using immunohistochemistry we localized FGFR4 in a panel of lung, breast, pancreas, and ovarian adenocarcinomas, lung squamous cell carcinoma, hepatocellular carcinoma, thyroid carcinoma, and normal lung, pancreas, and thyroid samples. This evidence concerns the gene FGFR4 and ovarian adenocarcinoma.